Firgun Ventures Launches $250 Million Quantum Fund, Closes First $70 Million Backed by Qatar Investment Authority

Firgun Ventures, the first VC firm focusing on Series A/B quantum companies, led by Kris Naudts, MD, PhD and Zeynep Korutürk, has launched a $250 million venture capital fund dedicated entirely to early-growth-stage quantum companies and announced its first close at $70 million. 

Backed by the Qatar Investment Authority, the fund is structured to support quantum companies in advancing from early pilot phases to deployable products positioned for use across sectors and regions in the real economy.

Founded by Dr. Kris Naudts and Zeynep Koruturk, Firgun Ventures is positioned to back the next generation of category-defining companies led by founders who can bridge scientific innovation and commercial adoption. The firm’s name reflects a principle of genuine support, expressed through a “first, do no harm” approach that emphasises patient, values-driven capital and sustainable company building.

Firgun focuses on quantum computing, sensing, and communications, targeting teams that have progressed beyond proof-of-concept and are beginning to show product-market fit. The firm aims to support entrepreneurs using quantum technologies to drive long-term impact in fields such as healthcare, climate science, finance, and cybersecurity.

Early support from family offices and from Ilyas Khan, founder of Cambridge Quantum Computing (now Quantinuum), signals strong credibility within the quantum ecosystem and access to some of the field’s most advanced work. This mix of scientific rigour and financial expertise is intended to operate more like a strategic partner than a traditional investor.

Although the management team operates from London, the fund will deploy capital across North America, Europe, and other emerging quantum hubs. Its objective is to build a portfolio of Series A and B companies that will shape the first commercial wave of quantum technologies, advancing beyond distant research concepts to become essential tools integrated into sectors ranging from pharmaceuticals to logistics.